annual EBITDA:
-$241.49M-$64.63M(-36.54%)Summary
- As of today (May 29, 2025), NAMS annual EBITDA is -$241.49 million, with the most recent change of -$64.63 million (-36.54%) on December 31, 2024.
- During the last 3 years, NAMS annual EBITDA has fallen by -$200.12 million (-483.74%).
- NAMS annual EBITDA is now -3533.17% below its all-time high of -$6.65 million, reached on December 1, 2020.
Performance
NAMS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$68.87M+$42.82M(+38.34%)Summary
- As of today (May 29, 2025), NAMS quarterly EBITDA is -$68.87 million, with the most recent change of +$42.82 million (+38.34%) on March 31, 2025.
- Over the past year, NAMS quarterly EBITDA has dropped by -$13.41 million (-24.17%).
- NAMS quarterly EBITDA is now -188.90% below its all-time high of -$23.84 million, reached on September 30, 2024.
Performance
NAMS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$255.78M-$13.41M(-5.53%)Summary
- As of today (May 29, 2025), NAMS TTM EBITDA is -$255.78 million, with the most recent change of -$13.41 million (-5.53%) on March 31, 2025.
- Over the past year, NAMS TTM EBITDA has dropped by -$62.08 million (-32.05%).
- NAMS TTM EBITDA is now -562.33% below its all-time high of -$38.62 million, reached on March 31, 2023.
Performance
NAMS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NAMS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.5% | -24.2% | -32.0% |
| 3 y3 years | -483.7% | - | - |
| 5 y5 years | -3533.2% | - | - |
NAMS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -981.0% | at low | -188.9% | +38.3% | -562.3% | at low |
| 5 y | 5-year | -3533.2% | at low | -188.9% | +38.3% | -562.3% | at low |
| alltime | all time | -3533.2% | at low | -188.9% | +38.3% | -562.3% | at low |
NAMS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$68.87M(-38.3%) | -$255.78M(+5.5%) |
| Dec 2024 | -$241.49M(+36.5%) | -$111.69M(+368.5%) | -$242.38M(+33.4%) |
| Sep 2024 | - | -$23.84M(-53.6%) | -$181.67M(-11.9%) |
| Jun 2024 | - | -$51.38M(-7.4%) | -$206.10M(+6.4%) |
| Mar 2024 | - | -$55.47M(+8.8%) | -$193.71M(+9.5%) |
| Dec 2023 | -$176.86M | -$50.99M(+5.6%) | -$176.86M(+40.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$48.27M(+23.8%) | -$125.87M(+62.2%) |
| Jun 2023 | - | -$38.99M(+1.0%) | -$77.61M(+101.0%) |
| Mar 2023 | - | -$38.62M | -$38.62M |
| Dec 2022 | -$22.34M(-46.0%) | - | - |
| Dec 2021 | -$41.37M(+522.4%) | - | - |
| Dec 2020 | -$6.65M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual EBITDA?
- What is the all time high annual EBITDA for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual EBITDA year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly EBITDA?
- What is the all time high quarterly EBITDA for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly EBITDA year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM EBITDA?
- What is the all time high TTM EBITDA for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM EBITDA year-on-year change?
What is NewAmsterdam Pharma Company NV annual EBITDA?
The current annual EBITDA of NAMS is -$241.49M
What is the all time high annual EBITDA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual EBITDA is -$6.65M
What is NewAmsterdam Pharma Company NV annual EBITDA year-on-year change?
Over the past year, NAMS annual EBITDA has changed by -$64.63M (-36.54%)
What is NewAmsterdam Pharma Company NV quarterly EBITDA?
The current quarterly EBITDA of NAMS is -$68.87M
What is the all time high quarterly EBITDA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly EBITDA is -$23.84M
What is NewAmsterdam Pharma Company NV quarterly EBITDA year-on-year change?
Over the past year, NAMS quarterly EBITDA has changed by -$13.41M (-24.17%)
What is NewAmsterdam Pharma Company NV TTM EBITDA?
The current TTM EBITDA of NAMS is -$255.78M
What is the all time high TTM EBITDA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM EBITDA is -$38.62M
What is NewAmsterdam Pharma Company NV TTM EBITDA year-on-year change?
Over the past year, NAMS TTM EBITDA has changed by -$62.08M (-32.05%)